-
Mashup Score: 3EMERALD Ph III Study in discussion w/ Dr. Aditya Bardia (now FDA Approved) – ONC Brothers - 1 year(s) ago
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and…
Source: oncbrothers.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 4
Oncology (Cancer) / Hematologic Malignancies Approval Notifications
Categories: Hem/Oncs, Latest HeadlinesTweet-
3 @FDAOncology approvals in less than 24 hours: 1. #Pembrolizumab adj NSCLC 2. #Pirtobrutinib refractory Mantle cell lymphoma 3. #Elacestrant HR+ mESR1 advanced breast CA #CommunityOncology @OncoAlert @HemOncFellows @US_FDA #MedTwitter #OncEd #MedEd https://t.co/Gvwy3jEUAv
-
-
Mashup Score: 2GI ASCO 2023 Highlights with Dr. Mark Lewis – ONC Brothers - 1 year(s) ago
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and…
Source: oncbrothers.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Practice changing/informing studies from @ASCO #GI23 for community oncologists w/@marklewismd: - #SPOTLIGHT - #NAPOLI3 - 5FU bolus - #SUNLIGHT Full Interview: - https://t.co/FCEVbIJ8DM - Also on “Oncology Brothers” podcast @OncoAlert #OncEd #MedTwitter #gism #coloncancer https://t.co/oPd819qzca
-
-
Mashup Score: 2
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and…
Source: oncbrothers.comCategories: Hem/Oncs, Latest HeadlinesTweet-
To get the stage ready for upcoming GI @ASCO & to understand 1 of the most pivotal studies of 2022, we discuss #NICHE2 w/ @MyriamChalabi from @NKI_nl Full Int: - https://t.co/cjqS6TQbww - Also on “Oncology Brothers” podcast #OncJC #MedTwitter #OncEd #GISM #ChalabiPlot #GI23 https://t.co/5IOxHCjn9R
-
-
Mashup Score: 0
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and…
Source: oncbrothers.comCategories: Hem/Oncs, Latest HeadlinesTweet-
To reiterate the SoC for #bladdercancer, @apolo_andrea walks us through this Rx algorithm. To complete the series, #ProstateCancer w/@neerajaiims soon. Full Int: - https://t.co/kfIC9aJzkn - Also on “Oncology Brothers” podcast #gusm #MedTwitter #OncEd #MedEd @OncoAlert https://t.co/sqKLDrRQQr
-
-
Mashup Score: 1FDA-AACR Oncology Educational Fellowship - 2 year(s) ago
This fellowship is designed to promote scientific progress through exchange of scientific knowledge, collaborative learning, and research.
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet-
What do recent FDA-@AACR Oncology Educational Fellows say about the program? Here's a comment from Mai Tolba. #OCEProjectSocrates #MedEd #OncEd Apply now for the 2022-2023 fellowship: https://t.co/zT4zC1SD3j https://t.co/Vq3v90jORe
-
-
Mashup Score: 0
Short animated videos, which improved patient understanding of chemotherapy terminology in an underserved urban setting, were also successful in significantly improving understanding in a rural setti…
Source: American Cancer Society JournalsCategories: Hem/Oncs, Latest HeadlinesTweet-
Knowledge is a powerful thing Great example of a tool to increase understanding of #cancer treatments among lay persons #OncoPharm #OncTwitter #OncEd #MedEd #PharmEd #TwitteRx #patientadvocacy https://t.co/9agcF0YkUL
-
@dradityabardia from @MGHCancerCenter walks us through #EMERALD study & how to incorporate this recent approval of #elacestrant in our clinical practice: Full Int: - https://t.co/0RucWrTCy4 - Also on the “Oncology Brothers” podcast #OncJC #MedTwitter #OncEd #bcsm @FDAOncology https://t.co/MlEkofaA8v